Zymedyne aims to develop safer, more effective treatments for chronic, neuropathic pain by targeting human Cav3.2 “T-type” calcium channels that are known to be crucial in pain signalling. Unlike opioids, our technology aims to achieve pain relief without the detrimental side effects of weight gain, respiratory depression and addiction that plague current users of opioid-based medications.
Company Details
- Employees
- 3
- Founded
- -
- Address
- Calgary, Alberta, Ca
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://zymedyne.ca
- HQ
- Calgary, Alberta
Zymedyne Therapeutics Questions
Zymedyne Therapeutics's website is https://zymedyne.ca
Zymedyne Therapeutics's LinkedIn profile is https://ca.linkedin.com/company/zymedyne-therapeutics
Zymedyne Therapeutics has
3 employees.
View email and phone details for 3
employees at Zymedyne Therapeutics.
Zymedyne Therapeutics's industry is
Biotechnology Research
Zymedyne Therapeutics's top competitors are
Mhcombiotic Inc.,
Ngb Innovation,
My Fertility Labs,
Aphiotx,
Iishield,
Seerem,
Cannabiscuit Canada Ltd.,
Neurodyn Life Sciences Inc.,
Clinical Trial Hero,
Creative Protein Solutions.
Zymedyne Therapeutics's categories are Biotechnology Research
Zymedyne Therapeutics's founding year is 2020
